Bladzijde 1 van 21 resultaten
BACKGROUND
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis, and they regulate angiogenesis in a variety of processes. Undesirable or pathological angiogenesis is associated with diseases including diabetic retinopathy, psoriasis, cancer, rheumatoid
FIELD OF THE INVENTION
The present invention relates to a method for treating neuronal insult, such as caused by lack of oxygen, in neurons prone to Parkinsonian degeneration, by administering to a patient an ATP-sensitive potassium channel blocker.
BACKGROUND OF THE INVENTION
A species of potassium
BACKGROUND OF THE INVENTION
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or
BACKGROUND OF THE INVENTION
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or
BACKGROUND OF THE INVENTION
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or
BACKGROUND OF THE INVENTION
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or
BACKGROUND OF THE INVENTION
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or
BACKGROUND OF THE INVENTION
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or
BACKGROUND OF THE INVENTION
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or
BACKGROUND OF THE INVENTION
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the national stage of Application No. PCT/EP2007/052081, filed 6 Mar. 2007 (hereby incorporated by reference herein), which application claims priority from EPO Patent Application No. 06110745.4, filed 7 Mar., 2006.
The present invention
FIELD OF THE INVENTION
The present invention relates to cyclic urea derivatives, their synthesis, and their use as .alpha.v integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors .alpha.v.beta.3, .alpha.v.beta.5, and
FIELD OF THE INVENTION
This invention relates to the electrolytic copper plating liquid that contains the compound that includes sulfur atoms and a specific urea derivative, and also the electrolytic plating method that uses the said electrolytic copper plating liquid.
BACKGROUND OF THE
II.1. Chronic renal failure
II.2. Acute renal failure
II.3. Chronic or acute hepatopathy occurring with hyperammonemia
II.4. Congenital diseases with enzymatic alterations of the urea cycle
II.5. Pathological human conditions having negative nitrogen balance, namely:
II.5.1. Sepsis
II.5.2.
TECHNICAL FIELD
The present invention relates to an exhaust gas purification system for a construction machine, and particularly relates to an exhaust gas purification system that injects a liquid reductant such as an aqueous urea solution into exhaust gas from an engine and that purifies NOx